livescience.com·Apr 19, 2026
A duo has been awarded a $3 million prize for their groundbreaking research that led to the development of the first CRISPR therapy for sickle cell disease.
The content highlights a noteworthy achievement in gene editing: a $3 million prize awarded to researchers for their groundbreaking work leading to the first CRISPR therapy for sickle cell disease. This underscores the growing impact of CRISPR technology in clinical applications and suggests a promising avenue for further investment and research in gene-editing therapies.